Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus

por Richards, Hanno B., Satoh, Minoru, Shaw, Melody, Libert, Claude, Poli, Valeria, Reeves, Westley H.
Publicado 1998

Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study

por Kivitz, Alan J., Wagner, Ulf, Dokoupilova, Eva, Supronik, Jerzy, Martin, Ruvie, Talloczy, Zsolt, Richards, Hanno B., Porter, Brian
Publicado 2018

Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus

por Li, Yi, Lee, Pui Y, Sobel, Eric S, Narain, Sonali, Satoh, Minoru, Segal, Mark S, Reeves, Westley H, Richards, Hanno B
Publicado 2009

Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

por Tahir, Hasan, Deodhar, Atul, Genovese, Mark, Takeuchi, Tsutomu, Aelion, Jacob, Van den Bosch, Filip, Haemmerle, Sibylle, Richards, Hanno B.
Publicado 2017

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis

por van der Heijde, Désirée, Braun, Jürgen, Deodhar, Atul, Baraliakos, Xenofon, Landewé, Robert, Richards, Hanno B, Porter, Brian, Readie, Aimee
Publicado 2019

Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases

por Yamasaki, Yoshioki, Narain, Sonali, Hernandez, Liza, Barker, Tolga, Ikeda, Keigo, Segal, Mark S, Richards, Hanno B, Chan, Edward KL, Reeves, Westley H, Satoh, Minoru
Publicado 2006

Effect of Secukinumab on Patient‐Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)

por Deodhar, Atul A., Dougados, Maxime, Baeten, Dominique L., Cheng‐Chung Wei, James, Geusens, Piet, Readie, Aimee, Richards, Hanno B., Martin, Ruvie, Porter, Brian
Publicado 2016

Secukinumab 150/300 mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 3‐Year Results from the Phase 3 MEASURE 3 Study

por Pavelka, Karel, Kivitz, Alan J., Dokoupilova, Eva, Blanco, Ricardo, Maradiaga, Marco, Tahir, Hasan, Wang, Yi, Porter, Brian O., Stefanska, Anna, Richards, Hanno B., Rohrer, Susanne
Publicado 2020

Brief Report: Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis

por van der Heijde, Désirée, Landewé, Robert B., Mease, Philip J., McInnes, Iain B., Conaghan, Philip G., Pricop, Luminita, Ligozio, Greg, Richards, Hanno B., Mpofu, Shephard
Publicado 2016

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Stu...

por Deodhar, Atul, Blanco, Ricardo, Dokoupilová, Eva, Hall, Stephen, Kameda, Hideto, Kivitz, Alan J., Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S., Porter, Brian O., Richards, Hanno B., Haemmerle, Sibylle, Braun, Jürgen
Publicado 2020

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

por Braun, Jürgen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S., van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S., Porter, Brian O., Shete, Abhijit, Richards, Hanno B., Haemmerle, Sibylle, Deodhar, Atul
Publicado 2021

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis

por Braun, Juergen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S., Van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, van der Heijde, Désirée, Zhuang, Tingting, Stefanska, Anna, Readie, Aimee, Richards, Hanno B., Deodhar, Atul
Publicado 2023

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Cl...

por GOTTLIEB, Alice B., DEODHAR, Atul, MCINNES, Iain B., BARALIAKOS, Xenofon, REICH, Kristian, SCHREIBER, Stefan, BAO, Weibin, MARFO, Kwaku, RICHARDS, Hanno B., PRICOP, Luminita, SHETE, Abhijit, TRIVEDI, Vivek, KEEFE, Deborah, PAPAVASSILIS, Charis C., JAGIELLO, Piotr, PAPANASTASIOU, Philemon, MEASE, Philip J., LEBWOHL, Mark
Publicado 2022